Severe Infections in Patients Treated with Tocilizumab for Systemic Diseases Other Than Rheumatoid Arthritis: A Retrospective Multicenter Observational Study

OBJECTIVE: This study aimed to describe severe infections in patients treated with tocilizumab for systemic diseases other than rheumatoid arthritis. METHODS: Data from patients receiving at least 2 doses of tocilizumab for systemic diseases other than rheumatoid arthritis between January 1, 2012, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Broca, Florent, Souchaud-Debouverie, Odile, Liuu, Evelyne, Roblot, Pascal, Martin, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mesut Onat 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152110/
https://www.ncbi.nlm.nih.gov/pubmed/36135932
http://dx.doi.org/10.5152/eurjrheum.2022.22028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152110/
https://www.ncbi.nlm.nih.gov/pubmed/36135932
http://dx.doi.org/10.5152/eurjrheum.2022.22028

Ejemplares similares